New LaunchJun 5, 2026, 09:26 AM
Cosmos Health launches Oliv18™ for $33B+ cardiovascular, antioxidant markets
AI Summary
Cosmos Health Inc. announced the U.S. launch of Oliv18™, a new USDA and EU organic certified, 100% solvent-free whole olive polyphenol formulation. This product expands its 18 Series nutraceutical platform into the cardiovascular health and antioxidant categories, targeting a combined global market projected to exceed $33 billion by 2035. A single daily dose of Oliv18™ delivers polyphenols equivalent to approximately 11 teaspoons of extra virgin olive oil and meets EFSA's minimum dose for LDL oxidation protection.
Key Highlights
- Cosmos Health launched Oliv18™ nutraceutical in the U.S.
- Oliv18™ is USDA and EU organic certified, 100% solvent-free.
- Targets cardiovascular health and antioxidant markets.
- U.S. cardiovascular market projected to reach $3.27B by 2030.
- U.S. antioxidant market projected to reach $3.18B by 2035.
- Global combined market projected to exceed $33B by 2035.
- Daily 250 mg dose meets EFSA's 5 mg hydroxytyrosol minimum.
- Delivers polyphenols equivalent to ~11 teaspoons of olive oil.
Price Impact
More from COSM